Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 14Prostatic Neoplasms 3Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Vaginal Neoplasms 2Pancreatic Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Vulvar Neoplasms 1Uveitis 1Uveal Melanoma 1Sarcoma 1Precancerous Conditions 1Papillomavirus Infections 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Malignant mesenchymal tumor 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Esophageal Squamous Cell Carcinoma 1Desmoplastic Small Round Cell Tumor 1Choroid Neoplasms 1Carcinosarcoma 1Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 1X-Rays 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Congresses as Topic 1Cisplatin 1Carboplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Locally Advanced Cervical Adenocarcinoma × Brachytherapy × Clear all
NCT07061977 2026-06-05

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
336 enrolled
Gynecologic

Locally Advanced Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡